93 related articles for article (PubMed ID: 22829518)
41. Ferrimagnetic susceptibility contrast agents.
Bach-Gansmo T
Acta Radiol Suppl; 1993; 387():1-30. PubMed ID: 8390776
[TBL] [Abstract][Full Text] [Related]
42. Enhancement characteristics of ultrasmall superparamagnetic iron oxide particle within the prostate gland in patients with primary prostate cancer.
Li CS; Harisinghani MG; Lin WC; Braschi M; Hahn PF; Mueller PR
J Comput Assist Tomogr; 2008; 32(4):523-8. PubMed ID: 18664836
[TBL] [Abstract][Full Text] [Related]
43. Superparamagnetic iron oxide (SPIO)-enhanced liver MRI with ferucarbotran: efficacy for characterization of focal liver lesions.
Namkung S; Zech CJ; Helmberger T; Reiser MF; Schoenberg SO
J Magn Reson Imaging; 2007 Apr; 25(4):755-65. PubMed ID: 17335040
[TBL] [Abstract][Full Text] [Related]
44. Pulmonary MR angiography with ultrasmall superparamagnetic iron oxide particles as a blood pool agent and a navigator echo for respiratory gating: pilot study.
Ahlström KH; Johansson LO; Rodenburg JB; Ragnarsson AS; Akeson P; Börseth A
Radiology; 1999 Jun; 211(3):865-9. PubMed ID: 10352617
[TBL] [Abstract][Full Text] [Related]
45. Interstitial MR lymphography with iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits.
Taupitz M; Wagner S; Hamm B; Binder A; Pfefferer D
AJR Am J Roentgenol; 1993 Jul; 161(1):193-200. PubMed ID: 8517301
[TBL] [Abstract][Full Text] [Related]
46. Magnetic resonance nanoparticles for cardiovascular molecular imaging and therapy.
Cyrus T; Winter PM; Caruthers SD; Wickline SA; Lanza GM
Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):705-15. PubMed ID: 16076280
[TBL] [Abstract][Full Text] [Related]
47. Effect of superparamagnetic particles in agarose gels. A magnetic resonance imaging study.
Ericsson A; Lönnemark M; Hemmingsson A; Bach-Gansmo T
Acta Radiol; 1991 Jan; 32(1):74-8. PubMed ID: 2012737
[TBL] [Abstract][Full Text] [Related]
48. Imaging of small hepatic metastases of colorectal carcinoma: how to use superparamagnetic iron oxide-enhanced magnetic resonance imaging in the multidetector-row computed tomography age?
Motosugi U; Ichikawa T; Nakajima H; Sou H; Sano M; Sano K; Araki T; Iino H; Fujii H; Nakazawa T
J Comput Assist Tomogr; 2009; 33(2):266-72. PubMed ID: 19346857
[TBL] [Abstract][Full Text] [Related]
49. Development of long circulating magnetic particle imaging tracers: use of novel magnetic nanoparticles and entrapment into human erythrocytes.
Antonelli A; Szwargulski P; Scarpa ES; Thieben F; Cordula G; Ambrosi G; Guidi L; Ludewig P; Knopp T; Magnani M
Nanomedicine (Lond); 2020 Apr; 15(8):739-753. PubMed ID: 32207374
[No Abstract] [Full Text] [Related]
50. Position and orientation measurement of susceptibility markers using spectrally selective spin-echo projections.
Karimi H; Dominguez-Viqueira W; Cunningham CH
Magn Reson Med; 2016 Nov; 76(5):1563-1573. PubMed ID: 26599342
[TBL] [Abstract][Full Text] [Related]
51. Superspeed Bolus Visualization for Vascular Magnetic Particle Imaging.
Vogel P; Ruckert MA; Kampf T; Herz S; Stang A; Wockel L; Bley TA; Dutz S; Behr VC
IEEE Trans Med Imaging; 2020 Jun; 39(6):2133-2139. PubMed ID: 31940524
[TBL] [Abstract][Full Text] [Related]
52. A deflectable guiding catheter for real-time MRI-guided interventions.
Bell JA; Saikus CE; Ratnayaka K; Wu V; Sonmez M; Faranesh AZ; Colyer JH; Lederman RJ; Kocaturk O
J Magn Reson Imaging; 2012 Apr; 35(4):908-15. PubMed ID: 22128071
[TBL] [Abstract][Full Text] [Related]
53. Nonequilibrium magnetic response of anisotropic superparamagnetic nanoparticles and possible artifacts in magnetic particle imaging.
Mamiya H; Jeyadevan B
PLoS One; 2015; 10(3):e0118156. PubMed ID: 25775017
[TBL] [Abstract][Full Text] [Related]
54. Magnetic resonance imaging-guided endovascular interventions--are we there yet?
Kandarpa K
J Vasc Interv Radiol; 2013 Jun; 24(6):891-3. PubMed ID: 23707098
[No Abstract] [Full Text] [Related]
55. Stabilizing interventional instruments in the cardiovascular system: A classification of mechanisms.
Ali A; Dodou D; Smit G; Rink R; Breedveld P
Med Eng Phys; 2021 Mar; 89():22-32. PubMed ID: 33608122
[TBL] [Abstract][Full Text] [Related]
56. Using data redundancy gained by patch overlaps to reduce truncation artifacts in magnetic particle imaging.
Ahlborg M; Kaethner C; Knopp T; Szwargulski P; Buzug TM
Phys Med Biol; 2016 Jun; 61(12):4583-4598. PubMed ID: 27271804
[TBL] [Abstract][Full Text] [Related]
57. Lymphatic Tissue and Superparamagnetic Nanoparticles - Magnetic Particle Imaging for Detection and Distribution in a Breast Cancer Model.
Finas D; Baumann K; Sydow L; Heinrich K; Gräfe K; Rody A; Lüdtke-Buzug K; Buzug T
Biomed Tech (Berl); 2013 Aug; 58 Suppl 1():. PubMed ID: 24042920
[No Abstract] [Full Text] [Related]
58. Magnetic Particle Spectroscopy for the Quantification of Magnetic Nanoparticles in Living Cells.
Löwa N; Wiekhorst F; Metzkow S; Ludwig A; Trahms L
Biomed Tech (Berl); 2013 Aug; 58 Suppl 1():. PubMed ID: 24042788
[No Abstract] [Full Text] [Related]
59. Comparison of Open Scanner Designs for Interventional Magnetic Particle Imaging.
Wojtczyk H; Bringout G; Tenner W; Graeser M; Grüttner M; Sattel TF; Gräfe K; Haegele J; Duschka RL; Panagiotopoulos N; Vogt FM; Barkhausen J; Buzug TM
Biomed Tech (Berl); 2013 Aug; 58 Suppl 1():. PubMed ID: 24042921
[No Abstract] [Full Text] [Related]
60. Bare-Metal Stent Tracking with Magnetic Particle Imaging.
Wegner F; Friedrich T; Wattenberg M; Ackers J; Sieren MM; Kloeckner R; Barkhausen J; Buzug TM; Graeser M; von Gladiss A
Int J Nanomedicine; 2024; 19():2137-2148. PubMed ID: 38476277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
